Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cerevel Therapeutics Holdings Inc shares valued at $2,116,640 were sold by COLES N ANTHONY on Apr 01 ’24. At $42.33 per share, COLES N ANTHONY sold 50,000 shares. The insider’s holdings dropped to 15,638 shares worth approximately $0.65 million following the completion of this transaction.
Also, COLES N ANTHONY sold 50,000 shares, netting a total of over 2,050,550 in proceeds. Following the sale of shares at $41.01 each, the insider now holds 15,638 shares.
Before that, COLES N ANTHONY had sold 50,000 shares from its account. In a trade valued at $2,057,890, the Director traded Cerevel Therapeutics Holdings Inc shares for $41.16 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $0.65 million.
As published in a research note from TD Cowen on December 08, 2023, Cerevel Therapeutics Holdings Inc [CERE] has been rated down from an Outperform to a Market perform and the price target has been revised to $45. As of September 28, 2023, Piper Sandler has initiated its “an Overweight” rating for CERE. Earlier on August 03, 2023, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for CERE stock which previously was a “a Buy”.
Analyzing CERE Stock Performance
During the last five days, there has been a drop of approximately -1.21%. Over the course of the year, Cerevel Therapeutics Holdings Inc shares have dropped approximately -1.89%. Shares of the company reached a 52-week high of $43.59 on 02/15/24 and a 52-week low of $40.66 on 02/22/24. A 50-day SMA is recorded $41.92, while a 200-day SMA reached $32.48. Nevertheless, trading volume fell to 0.84 million shares from 1.44 million shares the previous day.
Support And Resistance Levels for Cerevel Therapeutics Holdings Inc (CERE)
According to the 24-hour chart, there is a support level at 41.33, which, if violated, would cause prices to drop to 41.07. In the upper region, resistance lies at 41.83. The next price resistance is at 42.07. RSI (Relative Strength Index) is 40.58 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.50, which suggests the price will decrease in the coming days. Percent R is at 70.03%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
